COMMUNIQUÉS West-GlobeNewswire

Predictive Technology Group Acquires Key DNA and Ancestry Assets
02/10/2018
SALT LAKE CITY, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC/PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through [...]
Teligent, Inc. Announces FDA Approval of Fluocinonide Ointment USP, 0.05%
02/10/2018
BUENA, N.J., Oct. 02, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]
Trident Brands Inc. Subsidiary Brain Armor Receives Health Canada Approval to Sell and Distribute in Canada
02/10/2018
Brookfield, WI, Oct. 02, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Trident Brands Inc. (OTCQB: TDNT), a biotech and nutraceutical company, announced it has received authorization to sell and distribute their Brain [...]
Exagen Featured in Eight Scientific Presentations at The 2018 ACR/ARHP Annual Meeting in Chicago, IL
02/10/2018
Leading immunology laboratory continues strides with first ever economic impact data for AVISE Lupus ALBUQUERQUE, NM and SAN DIEGO, CA, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics, the exclusive providers of [...]
FDA Approves SEYSARA™ (Sarecycline) for the Treatment of Moderate to Severe Acne
02/10/2018
– To be launched in U.S. by Almirall SA – Paratek earns $12 million milestone payment BOSTON, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical company focused on the [...]
Avivagen Retains ITG to Conduct Market Making Activities
02/10/2018
OTTAWA, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen), is pleased to announce that it has retained the services of Independent Trading Group (“ITG”) to conduct Market Making activities. ITG will [...]
Arbutus to Present at Chardan’s Genetic Medicines Conference
02/10/2018
WARMINSTER, Pa., Oct. 02, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that Dr. Mark J. Murray, [...]
Dermira and Christian Siriano Collaborate to Inspire People Living with Excessive Underarm Sweating to Feel Confident in Their Own Skin
02/10/2018
Mr. Siriano invites the millions of people living with hyperhidrosis in the U.S. to share their ‘sweat stories’ MENLO PARK, Calif., Oct. 02, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical [...]
Vaccinex, Inc. Presents Preliminary Data on Its Anti-Semaphorin 4D Monocolonal Antibody Technology at the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
02/10/2018
ROCHESTER, N.Y., Oct. 02, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and [...]
Assure Holdings to Present at the Rocky Mountain Microcap Conference III on October 9, 2018
02/10/2018
DENVER, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, has been invited to present at the Rocky [...]
Premier Biomedical, Inc. Discusses CBD Public Image Challenges and the Future Marketplace with Uptick Newswire’s Stock Day Podcast
02/10/2018
PHOENIX, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTCQB: BIEI ) (“Premier Biomedical, Inc.” or the “company”) is looking for new strategies and joint ventures to sell CBD. CEO and President of Premier [...]
Aleafia Submits Application to List on NASDAQ
02/10/2018
Up-Listing to NASDAQ to Provide Greater Exposure to U.S. Investors TORONTO, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. ( TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH ) (“ Aleafia “) or (the “Company“), one of Canada’s [...]
SeaSpine Announces Preliminary Results for Third Quarter 2018
02/10/2018
Increases 2018 Financial Outlook CARLSBAD, Calif., Oct. 02, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of [...]
Cognition Therapeutics Receives $16.6 Million Multiyear NIA Grant for Phase 2 SHINE Study of Elayta™ in Patients with Mild-to-Moderate Alzheimer’s Disease
02/10/2018
Pittsburgh, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on synaptic health and restoration in Alzheimer’s disease and other neurodegenerative disorders [...]
CareDx Profiles AlloSeq Suite of NGS Products at ASHI
02/10/2018
Expands portfolio with three new kitted transplant products launching in 2019 Delivers new insights into the clinical Transplantome by incorporating HLA plus additional genes contributing to successful transplant [...]
Yield10 Bioscience Obtains Nonregulated Status for its Novel CRISPR-Cas9 Triple Gene Edited Camelina Plant Lines to Boost Seed Oil Content
02/10/2018
--USDA-APHIS Response Marks Clearance of Yield10’s First Triple Genome-edited Plant Lines --Favorable Response Accelerates Path to U.S. Field Trials in 2019 WOBURN, Mass., Oct. 02, 2018 (GLOBE NEWSWIRE) -- Yield10 [...]
Arzeda and BP Sign Collaborative Joint Development Agreement
02/10/2018
SEATTLE and HOUSTON, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Arzeda, The Protein Design Company™, and BP announced a collaboration to develop a process for producing a renewable chemical with broad applications. This [...]
VBI Vaccines’ Late-Breaker Cytomegalovirus Abstract Chosen for Oral Presentation at IDWeek 2018
02/10/2018
Presentation to feature complete safety and immunogenicity dataset from the Phase 1 clinical study of VBI-1501 Oral presentation at IDWeek 2018 on Saturday, October 6 th , 2018, at 11:10 AM PDT CAMBRIDGE, Mass., Oct. 02 [...]
Arzeda Leverages Scalable Synthetic Biology Resources to Drive Computational Protein Design Platform
02/10/2018
Integration of Providers Demonstrates the Power of Bioeconomy SEATTLE and SAN FRANCISCO, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Arzeda, the Protein Design Company™, Twist Bioscience Corporation, TeselaGen Biotechnology Inc. [...]

Pages